Heterogeneity of lymphokyne-activated killer (LAK) populations at the clonal level: Both NK and CD3+, CD4−, CD8− clones efficiently mediate tumor cell killing
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 49 (1) , 91-100
- https://doi.org/10.1016/0090-1229(88)90098-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A γ-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activityNature, 1987
- Two forms of the T-cell receptor γ protein found on peripheral blood cytotoxic T lymphocytesNature, 1987
- A T-cell receptor γ/CD3 complex found on cloned functional lymphocytesNature, 1987
- Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.The Journal of Experimental Medicine, 1986
- T cell nature of some lymphokine‐activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cellsEuropean Journal of Immunology, 1986
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassayJournal of Immunological Methods, 1981
- T‐Cell Growth FactorImmunological Reviews, 1980